The Diagnostic Value of Automated Neutrophil and Monocyte Parameters in Early Recognition of Sepsis
DOI:
https://doi.org/10.21276/apalm.3552Keywords:
sepsis, cell population data, NEU-X, NEU-Y, MON-X, MON-YAbstract
Background: Sepsis is a medical emergency. Treatment for sepsis is effective only if started early, and a critical lapse of time may be detrimental. The existing blood biomarkers for sepsis, like CRP and Procalcitonin, suffer from cost-ineffectiveness and an additional sample to be handled. The Leukocyte Cell Population Data (CPD) include NEU-X, NEU-Y, MON-X, and MON-Y. NEU-X measures the structural complexity of neutrophils by sideward scatter (SSC), while NEU-Y measures the DNA and RNA content by sideward fluorescence light. Our study aimed to evaluate the utility and significance of NEU-X and NEU-Y in the early diagnosis of sepsis.
Methods: It was a prospective, observational study done over a period of one month at a tertiary care hospital, which included 300 participants admitted in the ICU: 150 adults with suspected sepsis and 150 healthy controls. Blood samples were collected in EDTA vials and run on a Sysmex XN-1000 automated hematology analyser for CBC (complete blood counts) and values of NEU-X, NEU-Y, MON-X, and MON-Y parameters.
Results: The median value of NEU-X, NEU-Y, and MON-Y demonstrated a significant p-value of <0.0001 between cases and controls. NEU-X had a sensitivity of 79.33% and specificity of 91.33% at a cut-off of >339, while NEU-Y exhibited sensitivity and specificity of 93.33% each at a cut-off of >727. MON-Y and MON-X had a cut-off value of ≤90.3 and ≤118.9, respectively.
Conclusion: The leukocyte CPD parameters-NEU-X, NEU-Y, and MON-Y-represent a promising set of data and can be helpful in the early diagnosis of sepsis.
References
1. Zhang W, Zhang Z, Pan S, Li J, Yang Y, Qi H, et al. The clinical value of hematological neutrophil and monocyte parameters in the diagnosis and identification of sepsis. Ann Transl Med. 2021 Nov;9(22):1680.
2. Luo Y, Lin J, Chen H, Zhang J, Peng S, Kuang M. Utility of neut-X, neut-Y and neut-Z parameters for rapidly assessing sepsis in tumor patients. Clin Chim Acta. 2013 Jun 25:422:5-9.
3. He Y, Liu Q, Wei L, Sun Z, Li W, Geng F, et al. The Value of Peripheral Blood Leukocyte Parameters in the Early Diagnosis and Clinical Prognosis of Sepsis. International Journal of Analytical Chemistry. 2023;2023:6052085.
4. Hayashida K, Kondo Y, Hara Y, Aihara M, Yamakawa K. Head-to-head comparison of procalcitonin and presepsin for the diagnosis of sepsis in critically ill adult patients: a protocol for a systematic review and meta-analysis. BMJ Open. 2017;7(5):e015359.
5. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10.
6. Shashikumar SP, Stanley MD, Sadiq I, Li Q, Holder A, Clifford GD, et al. Early sepsis detection in critical care patients using multiscale blood pressure ssure and heart rate dynamics. J Electrocardiol. 2017;50(5):739-43.
7. Shalini P, Rao PS, Rao S. A Diagnostic Utility of Cell Population Data (CPD) In Sepsis Using Automated Hematology Analysers. Ann Pathol Lab Med. 2019;6(5):A284-8. 6(5):A284-8
8. Urrechaga E. Reviewing the value of leukocytes cell population data (CPD) in the management of sepsis. Ann Transl Med. 2020 Aug;8(15):953.
9. Yona S, Jung S. Monocytes: subsets, origins, fates and functions. Curr Opin Hematol. 2010;17(1):53-9.
10. Gómez-Gerique JA, Ortiz MM, Torrealba MI, Leganés M, Guirado L, Alarcón M. Evaluation of the diagnostic and prognostic capacity of procalcitonin, protein C reactive, interleukin-6 and lipopolysaccharide binding protein in patients with suspicion of sepsis. Rev Lab Clin. 2010:3(1):12-19.
11. Lin CT, Lu JJ, Chen YC, Kok VC, Horng JT. Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department. PeerJ. 2017;5:e4094.
12. Florence Prieto M, Kilstein J, Bagilet D. Schiavi A, De Feo F, Dubin A. Protein C reactive as a prognostic factor of mortality in the intensive care unit. Medicina Intensiva. 2008;32(9):424-30.
13. Devia Jaramillo G, Ibáñez Pinilla M. Quick sequential organ failure assessment, sequential organ failure assessment, and procalcitonin for early diagnosis and prediction of death in elderly patients with suspicion of sepsis in the emergency department, based on sepsis-3 definition. Gerontology. 2022 2(3):171-180.
14. Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology. 2007;39(4):383-90.
15. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941-52.
16. Vernon C. Letourneau JL. Lactic acidosis: recognition, kinetics, and associated prognosis. Crit Care Clin. 2010 26(2):255-83.
17. Fan SL, Miller NS, Lee J, Remick DG. Diagnosing sepsis - The role of laboratory medicine. Clin Chim Acta. 2016 Sep 1:460:203-10.
18. Xu D. Clinical Applications of Leukocyte Morphological Parameters. Int J Pathol Clin Res. 2015;1(1):003.
19. Celik IH, Demirel G. Aksoy HT, Erdeve O, Tuncer E, Biyikli Z, et al. Automated determination of neutrophil VCS parameters in diagnosis and treatment efficacy of neonatal sepsis. Pediatr Res. 2012;71(1):121-5.
20. PS, Rao PS, A R SR, Anil M. Benny A, I S. Diagnostic Utility of Cell Population Data (CPD) In Sepsis Using Automated Hematology Analysers. Ann Pathol Lab Med. 2019 Mar 15;6(5):A284-288.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Taruna Bansal, Sonal Yadav, Garima Rakheja, Vijay Kumar

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
